KONINKLIJKE PHILIPS NV (PHIA.AS) Stock Fundamental Analysis
Europe - Euronext Amsterdam - AMS:PHIA - NL0000009538 - Common Stock
25.695 EUR
+0.05 (+0.21%)
We assign a fundamental rating of 3 out of 10 to PHIA. PHIA was compared to 68 industry peers in the Health Care Equipment & Supplies industry. PHIA has a bad profitability rating. Also its financial health evaluation is rather negative. PHIA has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
- PHIA had positive earnings in the past year.
- In the past year PHIA had a positive cash flow from operations.
- The reported net income has been mixed in the past 5 years: PHIA reported negative net income in multiple years.
- Of the past 5 years PHIA 4 years had a positive operating cash flow.
1.2 Ratios
- Looking at the Return On Assets, with a value of 0.63%, PHIA is doing worse than 64.71% of the companies in the same industry.
- Looking at the Return On Equity, with a value of 1.56%, PHIA is doing worse than 64.71% of the companies in the same industry.
- PHIA's Return On Invested Capital of 4.21% is on the low side compared to the rest of the industry. PHIA is outperformed by 61.76% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.63% | ||
| ROE | 1.56% | ||
| ROIC | 4.21% |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- PHIA has a Profit Margin of 0.93%. This is in the lower half of the industry: PHIA underperforms 64.71% of its industry peers.
- PHIA has a Operating Margin of 6.10%. This is in the lower half of the industry: PHIA underperforms 60.29% of its industry peers.
- PHIA's Operating Margin has declined in the last couple of years.
- With a Gross Margin value of 43.49%, PHIA is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
- PHIA's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.1% | ||
| PM (TTM) | 0.93% | ||
| GM | 43.49% |
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PHIA is destroying value.
- Compared to 1 year ago, PHIA has less shares outstanding
- The number of shares outstanding for PHIA has been increased compared to 5 years ago.
- Compared to 1 year ago, PHIA has a worse debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 2.02 indicates that PHIA is not a great score, but indicates only limited risk for bankruptcy at the moment.
- PHIA has a Altman-Z score (2.02) which is comparable to the rest of the industry.
- PHIA has a debt to FCF ratio of 14.51. This is a negative value and a sign of low solvency as PHIA would need 14.51 years to pay back of all of its debts.
- Looking at the Debt to FCF ratio, with a value of 14.51, PHIA is doing worse than 60.29% of the companies in the same industry.
- PHIA has a Debt/Equity ratio of 0.69. This is a neutral value indicating PHIA is somewhat dependend on debt financing.
- Looking at the Debt to Equity ratio, with a value of 0.69, PHIA is doing worse than 72.06% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 14.51 | ||
| Altman-Z | 2.02 |
ROIC/WACC0.67
WACC6.33%
2.3 Liquidity
- PHIA has a Current Ratio of 1.32. This is a normal value and indicates that PHIA is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Current ratio, with a value of 1.32, PHIA is in line with its industry, outperforming 41.18% of the companies in the same industry.
- A Quick Ratio of 0.86 indicates that PHIA may have some problems paying its short term obligations.
- With a Quick ratio value of 0.86, PHIA is not doing good in the industry: 64.71% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.32 | ||
| Quick Ratio | 0.86 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an nice 15.15% over the past year.
- Measured over the past years, PHIA shows a decrease in Earnings Per Share. The EPS has been decreasing by -7.17% on average per year.
- Looking at the last year, PHIA shows a decrease in Revenue. The Revenue has decreased by -1.43% in the last year.
- The Revenue has been growing slightly by 1.00% on average over the past years.
EPS 1Y (TTM)15.15%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%12.5%
Revenue 1Y (TTM)-1.43%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-1.71%
3.2 Future
- PHIA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.28% yearly.
- Based on estimates for the next years, PHIA will show a small growth in Revenue. The Revenue will grow by 3.00% on average per year.
EPS Next Y4.35%
EPS Next 2Y4.98%
EPS Next 3Y7.73%
EPS Next 5Y10.28%
Revenue Next Year-2.27%
Revenue Next 2Y0.25%
Revenue Next 3Y1.58%
Revenue Next 5Y3%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 17.36, which indicates a rather expensive current valuation of PHIA.
- Based on the Price/Earnings ratio, PHIA is valued cheaper than 89.71% of the companies in the same industry.
- PHIA is valuated rather cheaply when we compare the Price/Earnings ratio to 27.30, which is the current average of the S&P500 Index.
- PHIA is valuated correctly with a Price/Forward Earnings ratio of 16.83.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of PHIA indicates a somewhat cheap valuation: PHIA is cheaper than 70.59% of the companies listed in the same industry.
- PHIA's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.04.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.36 | ||
| Fwd PE | 16.83 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, PHIA is valued a bit cheaper than the industry average as 69.12% of the companies are valued more expensively.
- PHIA's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 42.81 | ||
| EV/EBITDA | 13.37 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PHIA does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)4
PEG (5Y)N/A
EPS Next 2Y4.98%
EPS Next 3Y7.73%
5. Dividend
5.1 Amount
- PHIA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
AMS:PHIA (1/14/2026, 10:13:42 AM)
25.695
+0.05 (+0.21%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-04 2025-11-04/bmo
Earnings (Next)02-17 2026-02-17/amc
Inst Owners44.83%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap24.74B
Revenue(TTM)17.78B
Net Income(TTM)165.00M
Analysts72.14
Price Target27.59 (7.37%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly Dividend0
Dividend Growth(5Y)-70.49%
DP199.39%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)22.57%
Min EPS beat(2)14.1%
Max EPS beat(2)31.04%
EPS beat(4)3
Avg EPS beat(4)13.85%
Min EPS beat(4)-11.97%
Max EPS beat(4)31.04%
EPS beat(8)3
Avg EPS beat(8)-0.89%
EPS beat(12)6
Avg EPS beat(12)18.79%
EPS beat(16)6
Avg EPS beat(16)4.51%
Revenue beat(2)0
Avg Revenue beat(2)-2.19%
Min Revenue beat(2)-2.4%
Max Revenue beat(2)-1.97%
Revenue beat(4)0
Avg Revenue beat(4)-2.34%
Min Revenue beat(4)-3.04%
Max Revenue beat(4)-1.96%
Revenue beat(8)0
Avg Revenue beat(8)-3.43%
Revenue beat(12)2
Avg Revenue beat(12)-1.64%
Revenue beat(16)2
Avg Revenue beat(16)-1.76%
PT rev (1m)-0.21%
PT rev (3m)1.12%
EPS NQ rev (1m)1.31%
EPS NQ rev (3m)3.65%
EPS NY rev (1m)0.43%
EPS NY rev (3m)3.91%
Revenue NQ rev (1m)0.16%
Revenue NQ rev (3m)-0.39%
Revenue NY rev (1m)-0.4%
Revenue NY rev (3m)-0.45%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.36 | ||
| Fwd PE | 16.83 | ||
| P/S | 1.39 | ||
| P/FCF | 42.81 | ||
| P/OCF | 20.16 | ||
| P/B | 2.34 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.37 |
EPS(TTM)1.48
EY5.76%
EPS(NY)1.53
Fwd EY5.94%
FCF(TTM)0.6
FCFY2.34%
OCF(TTM)1.27
OCFY4.96%
SpS18.47
BVpS10.96
TBVpS-1.42
PEG (NY)4
PEG (5Y)N/A
Graham Number19.1
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.63% | ||
| ROE | 1.56% | ||
| ROCE | 5.61% | ||
| ROIC | 4.21% | ||
| ROICexc | 4.21% | ||
| ROICexgc | 11% | ||
| OM | 6.1% | ||
| PM (TTM) | 0.93% | ||
| GM | 43.49% | ||
| FCFM | 3.25% |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y10.6%
ROICexgc growth 5Y-2.51%
ROICexc growth 3Y4.73%
ROICexc growth 5Y-6.98%
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
F-ScoreN/A
Asset Turnover0.68
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 14.51 | ||
| Debt/EBITDA | 2.93 | ||
| Cap/Depr | 46.69% | ||
| Cap/Sales | 3.65% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 49.6% | ||
| Profit Quality | 350.3% | ||
| Current Ratio | 1.32 | ||
| Quick Ratio | 0.86 | ||
| Altman-Z | 2.02 |
F-ScoreN/A
WACC6.33%
ROIC/WACC0.67
Cap/Depr(3y)50.01%
Cap/Depr(5y)53.78%
Cap/Sales(3y)3.94%
Cap/Sales(5y)4.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.15%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%12.5%
EPS Next Y4.35%
EPS Next 2Y4.98%
EPS Next 3Y7.73%
EPS Next 5Y10.28%
Revenue 1Y (TTM)-1.43%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-1.71%
Revenue Next Year-2.27%
Revenue Next 2Y0.25%
Revenue Next 3Y1.58%
Revenue Next 5Y3%
EBIT growth 1Y712.43%
EBIT growth 3Y0.03%
EBIT growth 5Y-7.17%
EBIT Next Year48.95%
EBIT Next 3Y19.49%
EBIT Next 5Y15.13%
FCF growth 1Y-45.51%
FCF growth 3Y-40.93%
FCF growth 5Y-1.73%
OCF growth 1Y-31.12%
OCF growth 3Y-32.38%
OCF growth 5Y-4.03%
KONINKLIJKE PHILIPS NV / PHIA.AS FAQ
Can you provide the ChartMill fundamental rating for KONINKLIJKE PHILIPS NV?
ChartMill assigns a fundamental rating of 3 / 10 to PHIA.AS.
What is the valuation status of KONINKLIJKE PHILIPS NV (PHIA.AS) stock?
ChartMill assigns a valuation rating of 4 / 10 to KONINKLIJKE PHILIPS NV (PHIA.AS). This can be considered as Fairly Valued.
Can you provide the profitability details for KONINKLIJKE PHILIPS NV?
KONINKLIJKE PHILIPS NV (PHIA.AS) has a profitability rating of 2 / 10.
How financially healthy is KONINKLIJKE PHILIPS NV?
The financial health rating of KONINKLIJKE PHILIPS NV (PHIA.AS) is 2 / 10.
Can you provide the dividend sustainability for PHIA stock?
The dividend rating of KONINKLIJKE PHILIPS NV (PHIA.AS) is 0 / 10 and the dividend payout ratio is 199.39%.